Global Ebola Vaccine  Market, By Strain Type (Zaire, Sudan, Tai Forest, Bundibugyo Virus),  Vaccine Type (Cad3-Zebov, Rvsv-Zebov),  Route Of Administration (Oral, Intravenous),  Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)  End-Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centres, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028